Home/Filings/4/0000921895-25-000650
4//SEC Filing

Ben-Tzvi Avraham 4

Accession 0000921895-25-000650

CIK 0001130166other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 4:47 PM ET

Size

5.8 KB

Accession

0000921895-25-000650

Insider Transaction Report

Form 4
Period: 2025-02-26
Transactions
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2025-02-26+700,000700,000 total
    Exercise: $0.33From: 2025-02-26Exp: 2035-02-26Common Stock (700,000 underlying)
Footnotes (1)
  • [F1]On February 26, 2025 (the "Grant Date"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the "Common Stock") of Cyclacel Pharmaceuticals, Inc. (the "Company") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date.

Issuer

Cyclacel Pharmaceuticals, Inc.

CIK 0001130166

Entity typeother

Related Parties

1
  • filerCIK 0001944721

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:47 PM ET
Size
5.8 KB